menu
    • menu

    Company profile for Relief Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Relief Therapeutics Holding AG (SIX: RLF) is a Swiss-based publicly-traded drug development company focusing primarily on the clinical development of peptides and proteins of natural or engineered origin to address unmet medical needs. Our expertise covers the entire R&D lifecycle up to market approval.Relief Therapeutics develops truly innovative treatment approaches based on solid scientific foundations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Relief TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Fondation EIP Bâtiment F2/F3 Avenue de Sécheron 15 1202 Genève
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://relieftherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Relief Therapeutics Shareholders Approve Merger With Neurox
    Relief Therapeutics Shareholders Approve Merger With Neurox

    14 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-14/relief-therapeutics-shareholders-approve-business-combination-with-neurox

    PHARMIWEB
    14 Nov 2025
    Share Share
    Relief Pharma Reports Positive Results In RLF-OD032 Study
    Relief Pharma Reports Positive Results In RLF-OD032 Study

    29 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-announces-positive-results-from-pivotal-bioequiva-1093029

    ACCESSWIRE
    29 Oct 2025
    Share Share
    Relief Therapeutics Proposes Business Merger with NeuroX
    Relief Therapeutics Proposes Business Merger with NeuroX

    29 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-announces-proposed-business-combination-with-neur-1054171

    ACCESSWIRE
    29 Jul 2025
    Share Share
    Relief Therapeutics gets FDA response for RLF-TD011 QIDP request
    Relief Therapeutics gets FDA response for RLF-TD011 QIDP request

    19 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-receives-fda-response-to-qidp-request-for-rlf-td0-1041346

    ACCESSWIRE
    19 Jun 2025
    Share Share
    Relief Gets FDA Rare Pediatric Tag For RLF-TD011
    Relief Gets FDA Rare Pediatric Tag For RLF-TD011

    22 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-receives-fda-rare-pediatric-disease-designation-f-1030787

    ACCESSWIRE
    22 May 2025
    Share Share
    Relief Therapeutics Reports 2024 Financial Results & Update
    Relief Therapeutics Reports 2024 Financial Results & Update

    10 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/relief-therapeutics-reports-2024-financial-results-and-provides-corpo-1013164

    ACCESSWIRE
    10 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search